Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1164-1169

  Dean, Nathan C ^a,b,c   Sperry, Paul ^b   Wikler, Matthew ^d,e   Suchyta, Mary S ^a,b,c   Hadlock, Carol ^b,c  

^a LDS HOSPITAL   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Peninsula Pharmaceuticals   (United States)

^e Mpex Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LIDOCAINE;

ADULT; AGED; ARTICLE; BAD TASTE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGH WITH PHLEGM; COUGHING; DECISION SUPPORT SYSTEM; DECREASED APPETITE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; FATIGUE; FEMALE; FEVER; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJECTION SITE PAIN; INTERVIEW; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONEY; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NONHUMAN; OPEN STUDY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; SCORING SYSTEM; SHORT FORM 12; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; TASTE DISORDER; THORAX PAIN; UNITED STATES; VOMITING; WHEEZING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CLARITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HUMANS; LENGTH OF STAY; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES;

EID: 33645795962     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1164-1169.2006     Document Type: Article

References (16)

1. Colice, G. L., M. A. Morley, C. Asche, and H. G. Birnbaum. 2004. Treatment costs of community-acquired pneumonia in an employed population. Chest 125:2140-2145.
2. Dean, N. C., M. P. Silver, and K. A. Bateman. 2000. Frequency of specialty physician care in community acquired pneumonia. Chest 117:393-397.
3. Dean, N. C., M. P. Silver, B. James, K. A. Bateman, C. J. Hadlock, and D. Hale. 2001. Decreased mortality following implementation of a treatment guideline for community-acquired pneumonia. Am. J. Med. 110:451-457.
4. Efron, B., and G. Gong. 1983. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am. Stat. 1983:36-48.
5. Food and Drug Administration. 2004. Package insert for gatifloxacin and clarithromycin. U.S. Food and Drug Administration, Washington, D.C.
6. File, T. M., J. Garau, F. Blasi, C. Chidiac, K. Klugman, H. Lode, J. R. Lonks, L. Mandell, J. Ramirez, and V. Yu. 2004. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 125:1888-1901.
7. Fine, M. J., T. Auble, D. Yealy, B. H. Hanusa, L. A. Weissfeld, D. E. Singer, C. M. Coley, T. J. Marrie, and W. N. Kapoor. 1997. A prediction rule to identify low-risk pneumonia patients with community-acquired pneumonia. N. Engl. J. Med. 336:243-250.
8. Hoenig, J. M., and D. M. Heisey. 2001. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am. Stat. 55:19-24.
9. Klein, J. P., and M. L. Moeschberger. 1997. Survival analysis. Springer Verlag, New York, N.Y.
10. Larsen, L. D. 1997. Functional status change across an episode of CAP. Am. J. Respir. Crit. Care Med. 155:a726.
11. Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, D. M. Musher, and C. Whitney. 2003. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Infect. Dis. Soc. Am. Clin. Infect. Dis. 37:1405-1433.
12. Mandell, L. A., T. J. Marrie, R. F. Grossman, A. W. Chow, R. H. Hyland, et al. 2000. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Clin. Infect. Dis. 31: 383-421.
13. Niederman, M. S., L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G. A. Sarosi, A. Torres, R. Wilson, and V. L. Yu. 2001. American Thoracic Society guidelines for the management of adults with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 163:1730-1754.
14. Niederman, M. S., J. S. McCombs, A. N. Unger, A. Kumar, and R. Popovian. 1998. The cost of treating community-acquired pneumonia. Clin. Ther. 20:820-837.
15. Suchyta, M. S., N. C. Dean, S. Narus, and C. J. Hadlock. 2001. Impact of a practice guideline for community-acquired pneumonia in an outpatient setting. Am. J. Med. 110:306-309.
16. Ware, J. E., M. Kosinski, D. M. Turner-Bowker, and B. Gandek. 2004. How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Quality Metric, Inc., Lincoln, R.I.